Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease

Kent, William D. T.; Hall, Stephen F.; Isotalo, Phillip A.; Houlden, Robyn L.; George, Ralph L.; Groome, Patti A.
November 2007
CMAJ: Canadian Medical Association Journal;11/20/2007, Vol. 177 Issue 11, p1357
Academic Journal
Background: Recent reports from North America and Europe have documented an annual increase in the incidence of differentiated thyroid carcinoma. We sought to investigate the relation between rates of detection, tumour size, age and sex. Methods: Using the Ontario Cancer Registry, we identified 7422 cases of differentiated thyroid carcinoma diagnosed from Jan. 1, 1990, to Dec. 31, 2001. We obtained pathology reports for a random 10% of the 7422 patients for each year of the study period. The sample represented all Cancer Care Ontario regions. We compared the size of the patients' tumours by year, sex and age. Results: As expected, the incidence of differentiated thyroid carcinoma increased over the 12-year period. A significantly higher number of small (= 2 cm), nonpalpable tumours were resected in 2001 than in 1990 ( p= 0.001). The incidence of tumours 2-4 cm in diameter remained stable. When we examined differences in tumour detection rates by age and sex, we observed a disproportionate increase in the number of small tumours detected among women and among patients older than 45 years. Interpretation: Our findings suggest that more frequent use of medical imaging has led to an increased detection rate of small, subclinical tumours, which in turn accounts for the higher incidence of differentiated thyroid carcinoma. This suggests that we need to re-evaluate our understanding of the trends in thyroid cancer incidence.


Related Articles

  • Sex, Age, and Birth Cohort Effects in Colorectal Neoplasms. Brenner, Hermann; Altenhofen, Lutz; Hoffmeister, Michael // Annals of Internal Medicine;6/1/2010, Vol. 152 Issue 11, p697 

    Background: Prevalence of advanced colorectal neoplasms increases with age and is higher among men than women. Crosssectional analyses estimated that men reach an equivalent prevalence at a much younger age than women. However, crosssectional estimates may be confounded by birth cohort effects....

  • MAGNITUDE AND LEADING SITES OF CANCER IN A TERTIARY CANCER CARE HOSPITAL OF WESTERN MAHARASHTRA. Agrawal, Kapil H.; Rajderkar, S. S. // National Journal of Community Medicine;Oct-Dec2011, Vol. 2 Issue 3, p443 

    Context: It is observed that cancers are increasingly seen in both genders and all the age groups due to a complex interaction of various risk factors. To implement the Public health intervention measures it is essential to have the baseline data regarding frequency, distribution of cancers in...

  • Numbers Needed to Decide. Woloshin, Steven; Schwartz, Lisa M. // JNCI: Journal of the National Cancer Institute;9/2/2009, Vol. 101 Issue 17, p1163 

    The authors comment on a study which examined perceptions of the risk reduction from cancer screening by men and women in nine European Union countries. They warn that the study results should be interpreted with caution due to several factors, including the researchers' use of a method that is...

  • Imagerie du syst�me stylo-hyo�dien : variabilit� chez l-homme. SCANTEIE, Raluca; PASQUET, G�rard // Actualit�s Odonto-Stomatologiques;dec2012, Issue 260, p365 

    The purpose of our study is to analyse the stylo-hyoid complex on the orthopantogram. It is based on 350 dental panoramic X-ray samples. It shows the length variability and the most common morphology according to the age and the sex of the patients.

  • Age- and Sex-Specific Risks of Colorectal Cancers in Diabetic Patients. Hua-Fen Chen; Chen, Peter; Ying-Hwa Su; Hui-Fang Su; Chung-Yi Li // Tohoku Journal of Experimental Medicine;Apr2012, Vol. 226 Issue 4, p259 

    Diabetes has been reported to increase the risk of colorectal neoplasm in most but not all studies. However, the data on age- and sex-specific incidence rates and relative risks associated with diabetes are limited. We carried out this population-based cohort study to investigate the overall...

  • Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer.  // World Journal of Surgical Oncology;2009, Vol. 7, p63 

    Background: Incidentally found thyroid lesions are frequently detected in patients undergoing FDG-PET/CT. The aim of this study was to investigate the prevalence of incidentally found thyroid lesions in patients undergoing FDG-PET/CT and determine the risk for thyroid cancer. Methods: FDG-PET/CT...

  • Association of the miR-149 Rs2292832 Polymorphism with Papillary Thyroid Cancer Risk and Clinicopathologic Characteristics in a Chinese Population. Wen-Jun Wei; Zhong-Wu Lu; Duan-Shu Li; Yu Wang; Yong-Xue Zhu; Zhuo-Ying Wang; Yi Wu; Yu-Long Wang; Qing-Hai // International Journal of Molecular Sciences;2014, Vol. 15 Issue 11, p20968 

    (1) Background: The genetic predisposition to papillary thyroid cancer (PTC) is far from clearly elucidated. Rs2292832 is a genetic polymorphism that located in the precursor of mir-149 and has been studied in diverse cancers. Thus far, the role of rs2292832 in PTC tumorigenesis and progression...

  • Three Distinctly Different Kinds of Papillary Thyroid Microcarcinoma should be Recognized: Our Treatment Strategies and Outcomes. Sugitani, Iwao; Toda, Kazuhisa; Yamada, Keiko; Yamamoto, Noriko; Ikenaga, Motoko; Fujimoto, Yoshihide // World Journal of Surgery;Jun2010, Vol. 34 Issue 6, p1222 

    Papillary microcarcinoma (PMC) of the thyroid generally follows a benign clinical course. However, treatment strategies remain controversial. According to our previous retrospective review of 178 patients with PMC who underwent surgery between 1976 and 1993, the most significant risk factors...

  • Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at Diagnosis. McLeod, Donald S.A.; Jonklaas, Jacqueline; Brierley, James D.; Ain, Kenneth B.; Cooper, David S.; Fein, Henry G.; Haugen, Bryan R.; Ladenson, Paul W.; Magner, James; Ross, Douglas S.; Skarulis, Monica C.; Steward, David L.; Xing, Mingzhao; Litofsky, Danielle R.; Maxon, Harry R.; Sherman, Steven I. // Thyroid;Oct2015, Vol. 25 Issue 10, p1097 

    Background: Thyroid cancer is unique for having age as a staging variable. Recently, the commonly used age cut-point of 45 years has been questioned. Objective: This study assessed alternate staging systems on the outcome of overall survival, and compared these with current National Thyroid...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics